Protagonist Therapeutics Inc (PTGX)
Debt-to-capital ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 675,295 | 531,915 | 541,324 | 560,444 | 336,677 | -643,045 | 294,068 | -570,480 | -536,755 | 243,616 | 267,978 | 301,778 | -409,362 | 329,660 | 357,447 | 259,334 | -283,811 | 169,590 | 167,485 | 62,666 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — | — | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $675,295K)
= 0.00
Protagonist Therapeutics Inc has consistently maintained a debt-to-capital ratio of 0.00 in the periods reported up to December 31, 2024, except for data not available for March 31, 2021, December 31, 2021, March 31, 2022, March 31, 2023, September 30, 2023, and December 31, 2023. This indicates that the company has not relied heavily on debt financing to fund its operations relative to its capital structure. A debt-to-capital ratio of 0.00 typically signifies that the company's capital structure is primarily composed of equity rather than debt. As such, the company may have a lower financial risk due to the absence of significant debt obligations.
Peer comparison
Dec 31, 2024